Modulation of DAPK1 expression by its alternative splice variant DAPK1-215 in cancer

QingShui Wang1, ShuYun Weng2, WenTing Zhong3

  • 1Fujian-Macao Science and Technology Cooperation Base of Traditional Chinese Medicine-Oriented Chronic Disease Prevention and Treatment, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350001, China. wangqingshui@fjnu.edu.cn.

PubMed
Abstract

Insights

A novel splice variant, DAPK1-215, acts as a molecular brake on Death-Associated Protein Kinase 1 (DAPK1) expression, impacting cancer cell migration and invasion. DAPK1-215 serves as a prognostic marker for liver cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Death-Associated Protein Kinase 1 (DAPK1) is a serine/threonine kinase involved in cell death, development, and disease.
  • The regulation of DAPK1 expression in cancer is not well understood.

Purpose of the Study:

  • To investigate the expression and functional role of the DAPK1 splice variant, DAPK1-215, in various cancer types.
  • To elucidate the mechanism by which DAPK1-215 affects DAPK1 expression and cancer cell behavior.
  • To assess the prognostic significance of DAPK1-215 and DAPK1 in liver cancer.

Main Methods:

  • Quantified DAPK1 and DAPK1-215 expression using qRT-PCR and Western blotting in cancer cell lines.
  • Assessed cell migration, invasion, and proliferation in vitro and metastatic potential in a zebrafish model.
  • Utilized RNA pull-down and CLIP-seq to identify RNA-binding proteins.
  • Analyzed clinical liver cancer specimens for prognostic relevance.

Main Results:

  • DAPK1-215 downregulated DAPK1 expression by reducing mRNA stability in liver, kidney, and gastric cancer cells.
  • DAPK1-215 promoted migration and invasion in liver and kidney cancer but inhibited these in gastric cancer cells.
  • DEAD-Box Helicase 3 X-Linked (DDX3X) stabilized both DAPK1 and DAPK1-215 mRNAs, suggesting competition for binding.
  • High DAPK1-215 levels correlated with poor prognosis in liver cancer, while high DAPK1 predicted better outcomes.

Conclusions:

  • DAPK1-215 functions as a molecular brake on DAPK1 expression, influencing cancer cell migration and invasion in a context-dependent manner.
  • DAPK1-215 is a significant regulator of malignant progression and a potential prognostic marker in liver cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.9K